发明名称 |
IDENTIFICATION AND USE OF PROTEASE INHIBITORS |
摘要 |
.beta.-amyloid peptide (.beta.AP) production in cell culture and in vivo is inhibited by administering aspartyl protease inhibitors, particularly inhibitors of proteases of cathepsin D. Useful aspartyl protease inhibitors can be selected in a two-step assay, where test compounds are first screened for aspartyl protease inhibition activity in vitro in noncellular assays. Those test compounds which are found to display protease inhibition activity are then tested in cellular assays for .beta.AP production inhibition. Those test compounds which are capable of inhibiting intracellular .beta.amyloid production may be incorporated in pharmaceutical compositions.
|
申请公布号 |
CA2129689(A1) |
申请公布日期 |
1995.02.10 |
申请号 |
CA19942129689 |
申请日期 |
1994.08.08 |
申请人 |
ELI LILLY AND COMPANY;ATHENA NEUROSCIENCES, INC. |
发明人 |
DOVEY, HARRY F.;JOHN, VARGHESE;LAGUZZA, BENNETT C.;LIEBERBERG, IVAN M.;LITTLE, SHEILA P.;SINHA, SUKANTO |
分类号 |
A61K31/13;A61K31/16;A61K31/165;A61K31/17;A61K31/18;A61K31/195;A61K31/215;A61K31/27;A61K31/335;A61K31/38;A61K31/40;A61K31/41;A61K31/415;A61K31/44;A61K31/47;A61K31/495;A61K38/55;(IPC1-7):C12Q1/37;A61K31/395;A61K38/05;C12Q1/02;C12Q1/68;G01N33/48;G01N33/566 |
主分类号 |
A61K31/13 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|